• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Fitbit hires Adam Pellegrini as VP of Digital Health

Fitbit hires Adam Pellegrini as VP of Digital Health

August 4, 2016
CenterWatch Staff

Fitbit has announced that Adam Pellegrini will join the company as vice president of Digital Health, beginning September 6. Pellegrini will be responsible for leading Fitbit’s vision, strategies and programs to further drive the company’s integration into healthcare systems around the world. In this new role, Pellegrini will harness the power of Fitbit’s products, software and services to help create better clinical health outcomes while identifying new revenue opportunities for the company, building on the momentum Fitbit has had to date with disease management, insurance and wellness programs.

Pellegrini brings more than 20 years of experience across multiple sectors of the healthcare industry including providers, insurers, health technology and nonprofits. He joins Fitbit from Walgreens Boots Alliance, where he was the vice president of Digital Health, responsible for revolutionizing how the global chain approached omni-channel digital healthcare, including advancing the company’s integration with wearables, launching telemedicine and advancing their core digital pharmacy platforms. As part of his work with Walgreens, his team led the largest retail mHealth integration of more than 1 million connected devices and launched the company’s first integration of wearables—including Fitbit devices—with its Balance Rewards program, which rewards customers for making healthy choices.

“Over the past nine years, we’ve enabled millions of people around the world to lead healthier, more active lives by helping them to be more active, sleep better, eat smarter, and manage their weight. These are some of the very changes healthcare systems and disease management programs encourage people to make to help prevent or mitigate chronic diseases such as diabetes, hypertension and obesity,” said Woody Scal, chief business officer of Fitbit. “Because of this, we believe that Fitbit can play a meaningful role in the digital health revolution, and Adam is the ideal person to lead our efforts. He brings tremendous experience, leadership and vision to help us further develop and integrate our tools into healthcare, including areas such as behavior change programs, chronic care management, population screening, precision medicine, and remote monitoring for post discharge and care transitions.”

Pellegrini is tasked with helping Fitbit connect its products, information, data and insights in new and innovative ways into clinical settings. He will also focus on developing new partnerships with healthcare systems, insurers and other payers, pharma companies and medical device manufacturers.

“Fitbit is uniquely positioned to help drive better health outcomes by incorporating its innovative technology, renowned brand and powerful engagement into clinical healthcare programs,” said Pellegrini. “I’m a passionate believer in the power of digital health technology to improve the effectiveness, efficiency and reach of our healthcare system. I see a tremendous opportunity for healthcare providers, health plans and pharmaceutical companies to foster a more proactive, consumer-centric approach to healthcare using Fitbit’s products, software, services and extraordinary health brand.”

Fitbit currently partners with leading health management systems and insurers and recently announced its technology is being used in more than 200 clinical studies on conditions ranging from breast cancer and diabetes to heart disease and surgical recovery.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing